Market Place
Sourcing Support
FDA denies Ipsen`s citizen petition for blockbuster drug Somatuline
24 May 2024 //
ENDPTS
Cipla receives final approval for the generic version of Somatuline Depot Inj
23 May 2024 //
INDIANPHARMAPOST
Cipla gets USFDA nod to market Lanreotide injection
22 May 2024 //
ECONOMICTIMES
European Commission approves Mycapssa® for the treatment of Acromegaly
05 Dec 2022 //
GLOBENEWSWIRE
Ipsen says Autoinjector for Somatuline Autogel/ Somatuline Depot
15 Mar 2022 //
BUSINESSWIRE
Ipsen: Patient-Reported Data for Pain with Somatuline Autogel/Somatuline Depot
07 Mar 2022 //
BUSINESSWIRE
Cipla receives USFDA nod to market Lanreotide injection in US market
20 Dec 2021 //
EXPRESSPHARMA
Cipla gets USFDA nod for Lanreotide injection
20 Dec 2021 //
BUSINESS-STANDARD
Ipsen Announces New Data from the Phase II CLARINET FORTE Study Demonstrated
22 Feb 2021 //
BUSINESSWIRE
Ipsen Announces first efficacy & safety data from the CLARINET FORTE study
18 Sep 2020 //
BIOSPACE
Phase II CLARINET FORTE Results Show Increasing Dose of Somatuline Autogel
17 Sep 2020 //
BIOSPACE
Chiasma Announces U.S. Commercial Launch and Availability of MYCAPSSA®
31 Aug 2020 //
GLOBENEWSWIRE
Revenue growth at Ipsen numbs pain of palovarotene calamity
14 Feb 2020 //
PMLIVE
New InvgClinical Data for Ipsen’s Oncology Products in 11 Solid Tumor
24 May 2019 //
BUSINESSWIRE
U.S. FDA Approves New Indication for Ipsen`s Somatuline® Depot (lanreotide) Inj
18 Sep 2017 //
BUSINESSWIRE
Ipsen wins approval for gastroenteropancreatic neuroendocrine tumor drug
05 Jul 2017 //
DRUG DELIVERY
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.